Skip to main content

Table 6 Univariate Cox regression analysis for locoregional failure and distant failure for subjects without recurrence or death in the first two years

From: Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5 year follow-up

  Locoregional failure Distant failure
  Event HR 95% CI PValue Event HR 95% CI PValue
Gender         
 Male (n = 76) 5 1.00    9 1.00   
 Female (n = 21) 2 1.41 0.27-7.29 0.68 0 -- -- --
WHO Classification         
 Type III (n = 59) 2 1.00    6 1.00   
 Type II (n = 35) 5 4.39 0.85-22.62 0.08 3 0.83 0.21-3.33 0.79
 Type I (n = 3) 0 -- -- -- 0 -- -- --
cT         
 T1-2 (n = 62) 3 1.00    4 1.00   
 T3-4 (n = 35) 4 2.47 0.55-11.05 0.24 5 2.25 0.61-8.41 0.22
cN         
 N0-1 (n = 27) 1 1.00    2 1.00   
 N2-3 (n = 70) 6 2.64 0.32-22.02 0.37 7 1.49 0.31-7.19 0.62
Stage         
 IIB/III (n = 72) 4 1.00    7 1.00   
 IVA/IVB (n = 25) 3 2.31 0.52-10.35 0.27 2 0.79 0.16-3.82 0.77
Treatment         
 CCRT group (n = 68) 2 1.00    5 1.00   
 NACT group (n = 29) 5 6.31 1.22-32.59 0.03 4 1.87 0.50-6.96 0.35